Pharma and Healthcare Insight provides pharma market intelligence, trend analysis, forecasts and company profiles for the pharma industry on a country-by-country basis across North and South America, Central, Eastern and Western Europe, Asia, the Middle East and Africa. It gives access to the latest independent analysis of market data for the global pharma industry as well as a searchable archive of past articles and data.
ยป To access our 
RSS feed of headlines copy this link to your RSS reader
Industry / Ecuador
In 2009, pharmaceutical spending in Ecuador reached US$0.966bn and BMI calculates that it will increase further, by 8.80%, to a value of US$1.05bn in 2010. Despite a compound annual growth rate (CAGR) of 13.29% from 2004-2009, BMI's outlook for Ecuador's drug market is less optimistic over the next five years. From 2009-2014, a CAGR of 8.85% is projected, which we believe will...
2010-03-11Companies / United States
BMI believes that the introduction of legislation to ban pay-to-delay (pay-for-delay, reverse payment) settlements, either within a finalised US healthcare reform bill or as a separate...
2010-03-08Industry / Canada
The Canadian pharmaceutical market is expected to continue on an upward compound annual growth rate (CAGR) of 2.55% in US dollar terms and 4.3% in local currency. Growth will be driven...
2010-03-05Industry / Australia
Asia Pacific's respect for intellectual property rights with regard to medicine has improved marginally over the past 12 months, according to the Pharmaceutical Research and Manufacturers of America (PhRMA)'s Special 301 Submission 2010 to the United States Trade Representative (USTR). The Philippines and Australia have been upgraded to 'Priority Watch' and 'Watch List' countries...
2010-03-09Industry / India
Aurobindo Pharma has a launched a new division that will provide dedicated contract research and manufacturing services (CRAMS). AuroSearch is targeting large and small biopharmaceutical...
2010-03-08Industry / India
BMI believes Bangalore-based Strides Arcolab's impressive growth trajectory is set to continue. The drugmaker operates from a low-cost base, is present in over 60 developed states...
2010-03-05Companies / Czech Republic
The presence of countries from BMI's Emerging Europe Region in the Pharmaceutical Research and Manufacturers of America (PhRMA)'s Special 301 Submission 2010 remains largely equivalent to 2009, indicating no major shift in intellectual property (IP) concerns in the region. Five countries' IP environments are deemed to warrant concern from the PhRMA - Czech Republic, Hungary, Poland,...
2010-03-11Industry / Slovakia
The next update to Slovakia's medicine price list is due in April 2010, with the Ministry of Health aiming to reference 90% of marketed products. This update is expected to bring...
2010-03-10Industry / Slovenia
The Slovenian government approved a draft Health Services Act in March 2010, laying the groundwork for system reform in the country. The act introduces a number of reforms that will...
2010-03-09Industry / Ghana
The pharmaceutical regulatory environment in Ghana is governed by the Food and Drugs Board (FDB) which in March 2010 reported the confiscation of batches of medicines manufactured in China which were found to be fake. The FDB has its own drug testing facilities, which tests medicines as part of its post-marketing surveillance strategy.
2010-03-11Industry / Egypt
The Egyptian pharmaceutical industry is growing steadily, with spending in this sector forecast to reach US$4.2bn by the end of 2014. With exports on the rise, we believe that the...
2010-03-11Industry
Health Ministers and pharmaceutical industry representatives operating in Africa met in South Africa during February 2010 to discuss the continent's prospects for research and development...
2010-03-09Industry / Germany
German Health Minister Philipp Roesler is considering the implementation of compulsory discounts and price freezes on pharmaceuticals in order to limit the rising cost of healthcare. Germany's per-capita pharmaceutical expenditure is high compared with other European markets and pharmaceutical expenditure in the world's third-largest market reached EUR38.15bn (US$53.73bn) in 2009....
2010-03-09Industry / Germany
Multinational drugmaker Bayer is looking to expand its presence in emerging markets and has highlighted the BRIC (Brazil, Russia, India and China), Mexico, South Korea and Turkey...
2010-03-05Industry / Finland
Finland's national pharmaceutical industry association, Pharma Industry Finland (PIF), has stated that the reference pricing system, implemented in April 2009, has generated EUR85mn...
2010-03-05
